Books:
Cavagnaro, Joy A., and Cosenza, Mary E. Translational Medicine: Optimizing Preclinical Safety Evaluation of Biopharmaceuticals. CRC Press, 2021.
Steinbach, T.J., Patrick, D.J., Cosenza, M.E. Toxicologic Pathology for Non-Pathologists, First Edition, Humana Press. 2019
Steinbach, T.J., Patrick, D.J., Cosenza, M.E. Toxicologic Pathology for Non-Pathologists, First Edition, Humana Press. 2019
Chapters:
Mary E. Cosenza, A. W. Hayes. Auditory Toxicology. Comprehensive Toxicology, Third Edition. Vol 6, pp 338-360. Elsevier Ltd. 2018.
Mary E. Cosenza. Introduction to the Study Director. Study Director Handbook. 2014. Wiley and Sons.
Mary E. Cosenza. Implementation of ICH S6: US Perspective. Preclinical Safety Evaluation of Biopharmaceuticals, Part II (111-121): 2008. Wiley & Sons.
Mary E. Cosenza. Safety Assessment of Biotechnology – Derived Therapeutics. Preclinical Development Handbook – Toxicology, 19: (695-711).
Mary E. Cosenza. Introduction to the Study Director. Study Director Handbook. 2014. Wiley and Sons.
Mary E. Cosenza. Implementation of ICH S6: US Perspective. Preclinical Safety Evaluation of Biopharmaceuticals, Part II (111-121): 2008. Wiley & Sons.
Mary E. Cosenza. Safety Assessment of Biotechnology – Derived Therapeutics. Preclinical Development Handbook – Toxicology, 19: (695-711).
Abstracts:
M. Cosenza, Toxicology Study Strategies for Biopharmaceutical in Comparison to Small Molecules. Drug Metabolism Reviews 40 (Suppl. 3): 16, 2008.
J. Atkinson, P. Cranmer, T. Saunders, M. Niehaus, S. Y. Smith, A. Varela, M. S. Ominsky, M. E. Cosenza, P. J. Kostenuik. AMG 162, a Fully Human RANKL Antibody, Increases Bone Mass and Bone Strength in Cynomolgus Monkeys. J Bone Min Res 20 (Suppl. 1): S294, 2005.
Wild S, Cosenza ME, Sullivan L, DiPalma C, Pabst T, Mancini A, Shoup S, Nazario I, Neervannan S, Hayward I, Bolon B, Davis H (2001). Comparative pathology of vehicles used for rapid in vivo screening of small molecules. Toxicologist 60: 375 [Abst. 1782].
Bolon B, Faust J, Storm N, Sarmiento U, Litzinger D, Kinstler O, Gegg C, Cosenza ME (2001). Cytoplasmic vacuoles in renal tubular epithelium of mice given polyethylene glycol (PEG) conjugated protein are reduced by altering PEG size and conformation. Toxicologist 60: 376 [Abst. 1788].
J. Atkinson, P. Cranmer, T. Saunders, M. Niehaus, S. Y. Smith, A. Varela, M. S. Ominsky, M. E. Cosenza, P. J. Kostenuik. AMG 162, a Fully Human RANKL Antibody, Increases Bone Mass and Bone Strength in Cynomolgus Monkeys. J Bone Min Res 20 (Suppl. 1): S294, 2005.
Wild S, Cosenza ME, Sullivan L, DiPalma C, Pabst T, Mancini A, Shoup S, Nazario I, Neervannan S, Hayward I, Bolon B, Davis H (2001). Comparative pathology of vehicles used for rapid in vivo screening of small molecules. Toxicologist 60: 375 [Abst. 1782].
Bolon B, Faust J, Storm N, Sarmiento U, Litzinger D, Kinstler O, Gegg C, Cosenza ME (2001). Cytoplasmic vacuoles in renal tubular epithelium of mice given polyethylene glycol (PEG) conjugated protein are reduced by altering PEG size and conformation. Toxicologist 60: 376 [Abst. 1788].